Navigation Links
Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Date:9/10/2012

HARRISBURG, Pa., Sept. 10, 2012 /PRNewswire-USNewswire/ -- Governor Tom Corbett announced today that ViroPharma Inc. – a homegrown biopharmaceutical company – will expand its operations in Exton, Chester County and create 151 new, high-paying jobs. 

"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Corbett. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians."

ViroPharma will nearly double its current available space by leasing an additional 71,000-square feet of office space to accommodate planned growth. The expansion will enable the company to retain its existing 188 employees and create at least 151 new jobs within three years.

The company received a $583,000 funding offer from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits.  

"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said ViroPharma President and CEO Vincent J. Milano. "We're committed to this area for the long-term and look forward to creating opportunities in this community."

The project was coordinated by the Governor's Action Team, or GAT, economic development professionals who work directly with businesses that are considering locating or expanding in Pennsylvania. GAT worked with the Chester County Economic Development Council (CCEDC) to support ViroPharma's expansion.

"Chester County is fortunate to have companies like ViroPharma who continually innovate and reinvent themselves," said CCEDC President and CEO Gary Smith.  "Their expansion is the latest evidence that the life science community in Chester County is alive and well."

Founded in 1994 by a small team of entrepreneurial scientists in Exton, ViroPharma is focused on developing drugs for rare diseases in which there is an unmet medical need. The organization has grown into an international biopharmaceutical company with significant operations in Europe, in addition to Pennsylvania.

For more information about ViroPharma, visit www.viropharma.com.  

For more information on the Governor's Action Team and Pennsylvania's other economic development initiatives, visit www.newPA.com or call 1-866-466-3972.

Media contacts:

Kelli Roberts, Governor's Office; 717-783-1116
Theresa Elliott, DCED; 717-783-1132


'/>"/>
SOURCE Pennsylvania Office of the Governor
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Third Quarter Results
2. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
3. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
4. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
5. Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs
6. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
10. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
11. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
(Date:2/20/2017)... -- Acute, Chronic and Prophylaxis GVHD The global ... of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market ... 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, ... How ... can exploit the future business opportunities emerging in this sector. ...
(Date:2/19/2017)... and ORLANDO, Fla. , ... NKTR ) today announced that positive Phase 1 ... patients with renal cell carcinoma (RCC) were presented at ... designed to expand specific cancer-fighting T cells and Natural ... and increase expression of PD-1 on these immune cells.  ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... health plan partners, announced during the 2017 Annual HIMSS Conference & Exhibition ... for diabetic patients and integrating eye care into mainstream healthcare delivery is ...
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be participating as ... the event will take place February 23-25, 2017 at the Calvin L. Rampton Salt ... #909 with three new ambulances on display. , “JEMS is a ...
(Date:2/19/2017)... , ... February 19, 2017 , ... ... for connected home healthcare, will join forces with Healthwise ® at ... Healthwise, the industry leader in evidence-based health education, technology and services, will ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to ... other Butler products. Ken was impressed with the safety and reliability of the ... product on his show. This endorsement by Ken Matthews can be heard on ...
(Date:2/18/2017)... ... February 18, 2017 , ... ... Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line ... other applications. Users can pick and choose from hand-crafted trend-setting designs with ...
Breaking Medicine News(10 mins):